Compare FN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FN | BNTX |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | Cayman Islands | Germany |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3B | 24.2B |
| IPO Year | 2007 | 2019 |
| Metric | FN | BNTX |
|---|---|---|
| Price | $495.51 | $97.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $513.43 | $133.46 |
| AVG Volume (30 Days) | 851.2K | ★ 966.8K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.21 | N/A |
| EPS | ★ 9.22 | N/A |
| Revenue | ★ $3,419,327,000.00 | N/A |
| Revenue This Year | $36.87 | N/A |
| Revenue Next Year | $17.91 | $3.37 |
| P/E Ratio | $54.10 | ★ N/A |
| Revenue Growth | ★ 18.60 | N/A |
| 52 Week Low | $272.49 | $79.81 |
| 52 Week High | $748.89 | $124.00 |
| Indicator | FN | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 35.70 | 64.21 |
| Support Level | $485.34 | $95.13 |
| Resistance Level | $508.51 | $112.93 |
| Average True Range (ATR) | 39.17 | 2.32 |
| MACD | -6.24 | 0.91 |
| Stochastic Oscillator | 6.39 | 87.63 |
Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.